ENTRY       554               CDS       T01001
NAME        AVPR2, ADHR, DI1, DIR, DIR3, NDI, V2R
DEFINITION  (RefSeq) arginine vasopressin receptor 2
ORTHOLOGY   K04228  arginine vasopressin receptor 2
ORGANISM    hsa  Homo sapiens (human)
PATHWAY     hsa04072  Phospholipase D signaling pathway
            hsa04080  Neuroactive ligand-receptor interaction
            hsa04962  Vasopressin-regulated water reabsorption
DISEASE     H00252  Congenital nephrogenic diabetes insipidus (NDI)
            H01294  Nephrogenic syndrome of inappropriate antidiuresis (NSIAD)
DRUG_TARGET Argipressin: D02983
            Conivaptan (DG00276): D01236 D07748
            Desmopressin (DG00497): D00291 D02235
            Lypressin: D00366
            Mozavaptane hydrochloride: D01855
            Ornipressin: D07227
            Terlipressin (DG00498): D06672 D08571
            Tolvaptan: D01213
            Vasopressin (DG00496): D00101 D09820
BRITE       KEGG Orthology (KO) [BR:hsa00001]
             Environmental Information Processing
              Signal transduction
               04072 Phospholipase D signaling pathway
                554 (AVPR2)
              Signaling molecules and interaction
               04080 Neuroactive ligand-receptor interaction
                554 (AVPR2)
             Organismal Systems
              Excretory system
               04962 Vasopressin-regulated water reabsorption
                554 (AVPR2)
            G protein-coupled receptors [BR:hsa04030]
             Class A. Rhodopsin family
              Pituitary hormone
               Vasopressin
                554 (AVPR2)
POSITION    Xq28
MOTIF       Pfam: 7tm_1 7TM_GPCR_Srsx 7TM_GPCR_Srv 7tm_4 Git3
DBLINKS     NCBI-GeneID: 554
            NCBI-ProteinID: NP_000045
            OMIM: 300538
            HGNC: 897
            Ensembl: ENSG00000126895
            Vega: OTTHUMG00000024227
            Pharos: P30518(Tclin)
            UniProt: P30518
AASEQ       371
            MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLA
            ALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQM
            VGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQ
            RNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGP
            SERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEA
            PLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTT
            ASSSLAKDTSS
NTSEQ       1116
            atgctcatggcgtccaccacttccgctgtgcctgggcatccctctctgcccagcctgccc
            agcaacagcagccaggagaggccactggacacccgggacccgctgctagcccgggcggag
            ctggcgctgctctccatagtctttgtggctgtggccctgagcaatggcctggtgctggcg
            gccctagctcggcggggccggcggggccactgggcacccatacacgtcttcattggccac
            ttgtgcctggccgacctggccgtggctctgttccaagtgctgccccagctggcctggaag
            gccaccgaccgcttccgtgggccagatgccctgtgtcgggccgtgaagtatctgcagatg
            gtgggcatgtatgcctcctcctacatgatcctggccatgacgctggaccgccaccgtgcc
            atctgccgtcccatgctggcgtaccgccatggaagtggggctcactggaaccggccggtg
            ctagtggcttgggccttctcgctccttctcagcctgccccagctcttcatcttcgcccag
            cgcaacgtggaaggtggcagcggggtcactgactgctgggcctgctttgcggagccctgg
            ggccgtcgcacctatgtcacctggattgccctgatggtgttcgtggcacctaccctgggt
            atcgccgcctgccaggtgctcatcttccgggagattcatgccagtctggtgccagggcca
            tcagagaggcctggggggcgccgcaggggacgccggacaggcagccccggtgagggagcc
            cacgtgtcagcagctgtggccaagactgtgaggatgacgctagtgattgtggtcgtctat
            gtgctgtgctgggcacccttcttcctggtgcagctgtgggccgcgtgggacccggaggca
            cctctggaaggggcgccctttgtgctactcatgttgctggccagcctcaacagctgcacc
            aacccctggatctatgcatctttcagcagcagcgtgtcctcagagctgcgaagcttgctc
            tgctgtgcccggggacgcaccccacccagcctgggtccccaagatgagtcctgcaccacc
            gccagctcctccctggccaaggacacttcatcgtga
///
